Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WK | WORKIVA INC | $4.38B | $806.98M | -$34.99M | -$66.58M | -$1.19 | 19.02% | 20.01% | N/A | N/A | 2025-10-29 | ||
| IAC | IAC INC | $2.89B | $3.09B | -$266.03M | -$448.05M | -$5.48 | -9.99% | 4.11% | N/A | N/A | 2025-11-10 | ||
| KAPA | KAIROS PHARMA LTD | $32.78M | $0.00 | -$4.70M | -$4.71M | -$0.34 | N/A | N/A | N/A | N/A | |||
| AIOT | POWERFLEET INC | $701.91M | $391.21M | $47.75M | -$38.91M | -$0.31 | 407.54% | 29.22% | N/A | N/A | |||
| CNTX | CONTEXT THERAPEUTICS INC | $72.84M | $0.00 | -$34.10M | -$34.21M | -$0.36 | N/A | N/A | N/A | N/A | 2025-11-05 | ||
| NKTX | NKARTA INC | $139.92M | $0.00 | -$97.90M | -$109.24M | -$1.47 | N/A | N/A | N/A | N/A | 2025-11-05 | ||
| SMLR | SEMLER SCIENTIFIC INC | $420.31M | $42.98M | $47.20M | $37.05M | $3.75 | -30.39% | 4.89% | 61.64% | 11.26% | 2025-11-03 | ||
| FANG | DIAMONDBACK ENERGY INC | $38.94B | $14.08B | $9.18B | $3.84B | $13.93 | 51.78% | 32.85% | -27.97% | N/A | 2025-11-10 | ||
| PASG | PASSAGE BIO INC | $22.09M | $0.00 | -$55.01M | -$56.86M | -$18.16 | N/A | N/A | N/A | N/A | |||
| CEVA | CEVA INC | $586.07M | $106.35M | -$1.11M | -$10.08M | -$0.42 | 7.71% | 1.44% | N/A | N/A | 2025-11-06 | ||
| DMAC | DIAMEDICA THERAPEUTICS INC | $362.34M | $0.00 | -$29.42M | -$29.56M | -$0.69 | N/A | N/A | N/A | N/A | 2025-11-05 | ||
| KRRO | KORRO BIO INC | $294.40M | $6.28M | -$85.36M | -$91.36M | -$9.75 | N/A | -32.47% | N/A | N/A | |||
| ENTA | ENANTA PHARMACEUTICALS INC | $159.48M | $64.81M | -$82.41M | -$92.01M | -$4.32 | -9.94% | -15.47% | N/A | N/A | |||
| PRO | PROS HOLDINGS INC | $721.60M | $342.71M | $1.99M | -$7.18M | -$0.16 | 7.96% | 5.65% | N/A | N/A | 2025-10-28 | ||
| KYMR | KYMERA THERAPEUTICS INC | $3.38B | $44.71M | -$267.03M | -$275.43M | -$3.48 | -49.51% | 36.32% | N/A | N/A | 2025-10-29 | ||
| DNUT | KRISPY KREME INC | $532.10M | $1.60B | $183.81M | -$21.66M | -$0.13 | -6.55% | N/A | N/A | N/A | 2025-11-06 | ||
| CARL | CARLSMED INC | $389.41M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| MTSR | METSERA INC | $3.59B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| SGMT | SAGIMET BIOSCIENCES INC | $206.84M | $0.00 | -$59.23M | -$59.38M | -$1.83 | -100.00% | N/A | N/A | N/A | 2025-11-12 | ||
| CZR | CAESARS ENTERTAINMENT INC | $5.39B | $11.37B | $3.64B | -$195.00M | -$0.92 | -0.15% | 43.72% | N/A | N/A | 2025-11-04 | ||
| MBX | MBX BIOSCIENCES INC | $363.32M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2025-11-06 | ||
| ICHR | ICHOR HOLDINGS LTD | $585.97M | $929.18M | $22.34M | -$20.69M | -$0.61 | 15.45% | 3.42% | N/A | N/A | 2025-11-03 | ||
| ESTC | ELASTIC NV | $9.38B | $1.55B | $42.69M | -$83.49M | -$0.79 | 17.42% | 27.15% | N/A | N/A | |||
| FLD | FOLD HOLDINGS INC | $154.41M | $39.02M | -$96.05M | -$99.49M | -$10.83 | 23.46% | N/A | N/A | N/A | 2025-11-12 | ||
| BNTX | BIONTECH SE | $23.53B | $3.39B | -$27.18M | -$405.65M | -$1.68 | 17.05% | 88.67% | N/A | N/A | 2025-11-03 | ||
| ORIC | ORIC PHARMACEUTICALS INC | $1.04B | $0.00 | -$136.06M | -$137.25M | -$1.89 | N/A | N/A | N/A | N/A | 2025-11-10 | ||
| SKYW | SKYWEST INC | $4.22B | $3.84B | $1.03B | $407.91M | $10.10 | 20.45% | 8.25% | 132.18% | 24.85% | 2025-10-30 | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $65.39M | $0.00 | -$65.61M | -$73.14M | -$1.64 | -100.00% | N/A | N/A | N/A | 2025-11-06 | ||
| TSHA | TAYSHA GENE THERAPIES INC | $823.84M | $8.10M | -$90.24M | -$92.72M | -$0.34 | -37.09% | N/A | N/A | N/A | 2025-11-13 | ||
| AKRO | AKERO THERAPEUTICS INC | $3.42B | $0.00 | -$264.34M | -$269.44M | -$3.75 | N/A | N/A | N/A | N/A | 2025-11-12 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.60B | $4.09B | $371.29M | -$404.84M | -$6.63 | 4.52% | 13.02% | N/A | N/A | 2025-11-05 | ||
| MSGS | MADISON SQUARE GARDEN SPORTS CORP | $5.07B | $1.04B | $7.60M | -$22.44M | -$0.93 | 1.18% | 11.49% | N/A | N/A | 2025-10-30 | ||
| UTI | UNIVERSAL TECHNICAL INSTITUTE INC | $1.48B | $782.69M | $134.88M | $54.57M | $1.08 | 14.69% | 18.38% | 191.89% | 26.01% | |||
| GFL | GFL ENVIRONMENTAL INC | $17.55B | $5.28B | $4.09B | $2.63B | $6.65 | 6.63% | 14.07% | N/A | N/A | 2025-10-29 | ||
| PXLW | PIXELWORKS INC | $53.83M | $33.96M | -$24.09M | -$27.97M | -$5.59 | -44.05% | -9.87% | N/A | N/A | 2025-11-11 | ||
| PPTA | PERPETUA RESOURCES CORP | $1.94B | $0.00 | -$21.97M | -$22.10M | -$0.31 | N/A | N/A | N/A | N/A | |||
| ENGN | ENGENE HOLDINGS INC | $305.61M | $0.00 | -$90.61M | -$94.72M | -$1.90 | N/A | N/A | N/A | N/A | |||
| CBIO | CRESCENT BIOPHARMA INC | $169.77M | $0.00 | -$40.02M | -$41.18M | -$34.93 | -100.00% | -100.00% | N/A | N/A | |||
| MAZE | MAZE THERAPEUTICS INC | $1.02B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| CSTL | CASTLE BIOSCIENCES INC | $627.16M | $346.27M | $32.57M | -$9.47M | -$0.31 | 20.40% | 40.81% | N/A | N/A | 2025-11-10 | ||
| CCI | CROWN CASTLE INC | $40.75B | $5.42B | -$2.44B | -$4.64B | -$10.67 | -2.52% | -1.23% | N/A | N/A | 2025-10-15 | ||
| CHA | CHAGEE HOLDINGS LTD | $3.04B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| TYRA | TYRA BIOSCIENCES INC | $656.09M | $0.00 | -$105.28M | -$105.83M | -$1.78 | N/A | N/A | N/A | N/A | 2025-10-30 | ||
| TARA | PROTARA THERAPEUTICS INC | $121.92M | $0.00 | -$50.52M | -$50.86M | -$1.57 | N/A | N/A | N/A | N/A | 2025-10-30 | ||
| JCAP | JEFFERSON CAPITAL INC | $1.03B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2025-11-13 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.